PLASMA TIMOLOL LEVELS AFTER ORAL AND INTRAVENOUS ADMINISTRATION

被引：32

作者：

ELSE, OF

SORENSON, H

EDWARDS, IR

机构：

[1] LEO LABS,DEPT CHEM,COPENHAGEN,DENMARK

[2] UNIV LEICESTER,DEPT PHARMACOL & THERAPEUT,LEICESTER LE1 7RH,W YORKSHIRE,ENGLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1978年 / 14卷 / 06期

关键词：

D O I：

10.1007/BF00716385

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：431 / 434

页数：4

共 12 条

[1]

ACHONG MR, 1976, CLIN PHARMACOL THER, V19, P148

[2] EFFECT OF TIMOLOL VERSUS PROPRANOLOL ON HYPERTENSION AND HEMODYNAMICS [J].

ARONOW, WS ;

FERLINZ, J ;

DELVICARIO, M ;

MOORTHY, K ;

KING, J ;

CASSIDY, J .

CIRCULATION, 1976, 54 (01) :47-51

[3]

BODEM G, 1973, CLIN PHARMACOL THER, V14, P26

[4] EMPIRICAL EQUATION FOR PHARMACOKINETIC ANALYSIS OF DRUG SERUM LEVELS AFTER ORAL APPLICATION [J].

ENGBERGPEDERSEN, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (05) :554-562

[5] PHARMACOKINETICS OF PINDOLOL IN MAN [J].

GUGLER, R ;

HEROLD, W ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :17-24

[6]

PATERSON J W, 1970, Pharmacologia Clinica, V2, P127, DOI 10.1007/BF00420338

[7]

REGARDH CG, 1975, ACTA PHARMACOL TO S1, V37

[8]

SHAND DG, 1976, POSTGRAD MED J, V52, P22

[9]

SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112

[10]

SORENSEN H, 1976, COMMUNICATION

← 1 2 →